Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 05:07:59 2026-09-01 am EDT			5-day change	1st Jan Change
60.30 ^EUR	-0.50%		+0.58%	-5.20%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.6B		BBB
ELI LILLY AND COMPANY	1,031B		A
JOHNSON & JOHNSON	641B	-	BBB	-	-
ABBVIE INC.	453B		AA		-
ROCHE HOLDING AG	349B		AA
NOVARTIS AG	290B		AAA
ASTRAZENECA PLC	252B		A
AMGEN INC.	232B		A
NOVO NORDISK A/S	201B		A
GILEAD SCIENCES, INC.	181B		AA
PFIZER INC.	162B		A
VERTEX PHARMACEUTICALS INCORPORATED	138B		AA
BRISTOL-MYERS SQUIBB COMPANY	136B		A
SANOFI	107B		AA
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.2B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	57.62B		AA
BAYER AG	55.96B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	45.1B		AA
HALEON PLC	43.95B		AA
Average	227.57B		AA
Weighted average by Cap.			AA